⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3067487 | 0.73 | — | — | |
| SCHEMBL28382049 | 0.72 | — | — | |
| SCHEMBL3279783 | 0.71 | — | — | |
| SCHEMBL4992488 | 0.71 | — | — | |
| SCHEMBL11857363 | 0.71 | NPC1 (0.33) | — | |
| SCHEMBL8043338 | 0.71 | — | — | |
| SCHEMBL9354423 | 0.71 | — | — | |
| SCHEMBL15014658 | 0.71 | — | — | |
| SCHEMBL8383713 | 0.71 | — | — | |
| SCHEMBL9354267 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4805909-B2 | — | — | 2011-11-02 | — | — | JP | claimed |
| EP-1725522-A1 | ANILINE DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS | SMITHKLINE BEECHAM CORPORATION (US) | 2006-11-29 | — | — | EP | claimed |
| WO-2005085185-A1 | ANILINE DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS | SMITHKLINE BEECHAM CORPORATION (US) | 2005-09-15 | — | — | WO | claimed |
| EP-4186900-A1 | CODRUG THAT DISINTEGRATES IN INTESTINE, PREPARATION THEREFOR, AND USE THEREOF | Ennovabio (Zhejiang) Pharmaceuticals Co., Ltd. (CN) | 2023-05-31 | — | — | EP | disclosed |
| WO-2022103842-A1 | OLIGONUCLEOTIDES, REAGENTS AND PREPARATION THEREOF | BIOGEN MA INC. (US) | 2022-05-19 | — | — | WO | disclosed |
| WO-2022012693-A1 | CODRUG THAT DISINTEGRATES IN INTESTINE, PREPARATION THEREFOR, AND USE THEREOF | 轶诺(浙江)药业有限公司 | 2022-01-20 | — | — | WO | disclosed |
| EP-2240276-B1 | IRON AND COPPER CATALYTIC SYSTEMS FOR CROSS-COUPLING REACTIONS | CENTRE NAT RECH SCIENT (FR) | 2020-12-02 | — | — | EP | disclosed |
| WO-2018130227-A1 | AROMATIC RING-CONTAINING COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USE | 山东罗欣药业集团股份有限公司 | 2018-07-19 | — | — | WO | disclosed |
| US-9861971-B2 | Catalytic system for cross-coupling reactions | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) (FR) | 2018-01-09 | — | — | US | disclosed |
| US-20160130205-A1 | CATALYTIC SYSTEM FOR CROSS-COUPLING REACTIONS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2016-05-12 | — | — | US | disclosed |
| US-9272274-B2 | Catalytic system for cross-coupling reactions | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2016-03-01 | — | — | US | disclosed |
| WO-2007075783-A2 | SUBSTITUTED ISOQUINOLINE-1,3(2H,4H)-DIONES, 1-THIOXO-1,4-DIHYDRO-2H-ISOQUINOLINE-3-ONES AND 1,4-DIHYDRO-3(2H)-ISOQUINOLONES AND USE THEREOF AS KINASE INHIBITOR | WYETH (US) | 2007-07-05 | — | — | WO | disclosed |
| US-20060148682-A1 | Tumor-activated prodrug compounds and treatment | LA REGION WALLONNE (BE) | 2006-07-06 | — | — | US | disclosed |
| US-7037898-B2 | Drug conguated to a ligand comprising an arm linked to a terminal group through a linkage that prevents intracellular entry of the conjugate, said linkage is selectively cleaved by factors secreted by target cells such as tumors | LAREGION WALLONE (BE) | 2006-05-02 | — | — | US | disclosed |
| US-20020160943-A1 | Tumor-activated prodrug compounds and treatment | TROUET ANDRE (BE) | 2002-10-31 | — | — | US | disclosed |
| US-6342480-B1 | STABILITY OF COMPOUNDS, TARGET CELLS AND ANTIINFLAMMATORY AGENTS | LA REGION WALLONE (BE) | 2002-01-29 | — | — | US | disclosed |
| US-5962216-A | MARKER OR ANTICARCINOGENIC/ANTIINFLAMMATORY/ANTITUMOR AGENT LINKED BY CLEAVABLE SEQUENCE TO STABILIZER OF BETA-ALANINE OR SUCCINIC ACID; TARGETED DELIVERY TO CELL, CLEAVAGE BY CELL SPECIFIC FACTOR FOR ENTRY INTO CELL OR EXPRESSION OF MARKER | LA REGION WALLONNE (BE) | 1999-10-05 | — | — | US | disclosed |
| EP-0769967-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITION AND DIAGNOSTIC DEVICE COMPRISING SAME AND THEIR USE | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 1997-05-02 | — | — | EP | disclosed |
| WO-1996005863-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITION AND DIAGNOSTIC DEVICE COMPRISING SAME AND THEIR USE | LA REGION WALLONNE (BE) | 1996-02-29 | — | — | WO | disclosed |
| US-4120819-A | SLURRYING WITH A CARBOXYLIC ACID OR MINERAL ACID, CONTACTING WITH OXYGEN | ASHLAND OIL, INC. (US) | 1978-10-17 | — | — | US | disclosed |